Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Portfolio Highlights: Clinical and Financing Updates of AIxplorerBIO, Genhouse, VivaVision, Domain, Amberstone, Anji and QurAlis 2022-07-27 21:30
Noul's Hydrogel Stamping is the potential core technology necessary for precise cancer diagnosis, study confirmed 2022-07-27 20:00
Samsung Biologics Reports Second Quarter 2022 Financial Results 2022-07-27 14:43
Vela Diagnostics Develops PCR-based Test for Detecting Monkeypox Virus 2022-07-26 22:09
Gracell Biotechnologies to Participate in BTIG 2022 Biotechnology Conference 2022-07-26 20:30
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Provisional Registration in Australia for Use in Adolescents Aged 12 Through 17 2022-07-26 20:00
Nuance Pharma announces the completion of dosing for all NTM-001 Phase 1 clinical study participants in HKU Clinical Trials Centre 2022-07-26 17:04
Ascentage Pharma and Tanner Pharma Group Initiate a Global Innovative Named Patient Program 2022-07-25 21:59
Anti-PD-1 monoclonal antibody Puyouheng™ (HX-008, Pucotenlimab injection) Co-developed by LEPU BIOPHARMA and HANX BIOPHARMACEUTICALS was approved for marketing in China by NMPA 2022-07-25 18:47
Alterity Therapeutics: Appendix 4C - Q4 FY22 Quarterly Cash Flow Report 2022-07-22 19:25
AI-based Cancer Solution Pioneer Lunit Makes Market Debut 2022-07-21 21:00
ImmVira's intravenous administered oHSV MVR-T3011 IV demonstrated promising clinical biological activities 2022-07-21 08:00
Gracell Biotechnologies Appoints Veteran BioPharma Executive Dr. Samuel Zhang as Chief Business Officer 2022-07-19 20:00
I-Mab to Present Phase 2 Clinical Data of CD47 Antibody Lemzoparlimab at ESMO Congress 2022 2022-07-18 20:00
OliPass Moves Forward to Second Stage of Phase 2a Trial for Pain Killer OLP-1002 2022-07-18 20:00
Samsung Biologics to purchase land for its second Bio Campus 2022-07-18 19:00
Lunit to be Listed on KOSDAQ next week 2022-07-14 21:00
Bridge Biotherapeutics to Present Interim Clinical Data from Ongoing Phase 1 Study of BBT-176 at the World Conference of Lung Cancer 2022-07-13 06:30
KAZIA LAUNCHES NEW SCIENTIFIC ADVISORY BOARD COMPRISED OF WORLD-LEADING EXPERTS IN BRAIN CANCER 2022-07-12 20:15
iNtRON Confirms Efficacy of CDL200 Against CDI Clinical Isolates 2022-07-12 10:06
1 73 74 75 76 77 220